Seres Therapeutics Balance Sheet (2015-2026) | MCRB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)	37.22M	38.72M	40.27M	41.84M	43.52M	45.27M	45.04M	46.44M	47.97M	49.65M	49.08M	52.40M	53.82M	52.17M	53.20M	54.27M	55.33M	56.38M	56.61M	57.39M
Assets
Current Assets
Cash & Equivalents (Quarter)	74.00M	353.18M	180.00M	248.00M	195.79M	233.00M	163.03M	94.84M	229.52M	169.91M	127.97M	111.18M	71.23M	66.82M	30.79M	58.85M	45.38M	47.64M	45.77M	29.83M
Receivables - Net (Quarter)	1.25M	1.25M													3.72M	7.40M		0.35M	0.16M
Receivables - Other (Quarter)								125.00M			8.67M		18.60M		2.68M	1.62M	0.28M	0.05M
Receivables (Quarter)	1.25M	1.25M													6.41M	9.03M		0.40M	0.16M
Raw Materials (Quarter)									0.55M	3.53M	4.43M	4.22M	4.93M
Work In Process (Quarter)									4.75M	14.99M	25.22M	37.27M	48.06M
Finished Goods (Quarter)									0.04M			0.48M
Inventory (Quarter)									5.34M	18.52M	29.65M	41.97M	53.00M
Prepaid Assets (Quarter)	8.75M	10.17M	12.92M	15.25M	13.79M	14.51M	13.42M	9.54M	8.82M	9.10M	8.05M	4.61M	6.43M	6.10M	5.81M	4.47M	2.42M	3.11M	3.09M	1.77M
Current Assets (Quarter)	224.56M	358.81M	303.63M	263.25M	209.58M	247.51M	194.76M	116.08M	251.24M	214.39M	175.41M	165.18M	149.26M	72.93M	38.67M	66.08M	48.69M	51.53M	49.38M	31.84M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	15.05M	17.36M	17.94M	19.07M	19.52M	19.48M	22.98M	24.31M	24.03M	23.57M	17.61M	19.11M	17.79M	12.57M	11.53M	10.55M	9.62M	8.58M	7.63M	6.85M
Long-Term Investments (Quarter)	2.15M	5.79M	0.49M	1.40M		1.40M	1.40M	1.40M	1.40M	1.40M	1.40M	1.40M
Other Non-Current Assets (Quarter)	0.60M	0.60M	5.19M	8.19M	8.19M	11.54M	8.19M	8.19M	11.25M	12.05M	39.17M	8.43M	41.52M		8.67M	0.03M	8.67M	0.03M	0.03M	0.03M
Non-Current Assets (Quarter)	45.09M	37.48M	51.23M	56.64M	63.62M	64.36M	154.02M	154.11M	155.15M	153.31M	183.19M	176.08M	172.47M	105.81M	101.14M	98.10M	95.11M	91.95M	88.82M	85.78M
Assets (Quarter)	269.65M	396.29M	354.86M	319.89M	273.20M	311.87M	348.78M	270.19M	406.39M	367.70M	358.60M	341.26M	321.73M	178.74M	139.81M	164.18M	143.80M	143.47M	138.19M	117.62M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	5.45M	8.62M	13.73M	6.79M	13.99M	10.45M	17.44M	12.30M	12.92M	8.96M	3.64M	5.22M	4.81M	8.25M	4.08M	2.17M	2.20M	1.68M	1.68M	2.34M
Notes Payables (Quarter)	6.30M	9.35M					0.46M
Payables (Quarter)	11.75M	17.97M	13.73M	6.79M	13.99M	10.45M	17.90M	12.30M	12.92M	8.96M	3.64M	5.22M	4.81M	8.25M	4.08M	2.17M	2.20M	1.68M	1.68M	2.34M
Accumulated Expenses (Quarter)	5.20M	48.90M	45.09M	5.29M	8.50M	59.17M	59.84M	44.36M	11.69M	13.48M	22.51M	6.14M	7.44M	17.72M	10.72M	6.22M	4.23M	4.44M	2.69M	2.86M
Other Accumulated Expenses (Quarter)	1.49M	1.63M	3.63M	1.45M	5.45M	4.13M	3.64M	6.48M	7.95M	2.93M	2.77M	1.99M	4.26M	6.69M	2.16M	2.63M	1.04M	1.51M	0.90M	0.64M
Current Leases (Quarter)	5.67M	6.10M	6.61M	6.85M	7.06M	7.33M	3.60M	4.78M	5.47M	6.28M	5.59M	8.83M	9.20M	8.35M	8.67M	9.05M	9.48M	9.92M	10.39M	10.87M
Current Deferred Revenue (Quarter)	19.83M	21.62M	16.82M	20.44M	11.10M	4.87M	4.26M	2.38M	0.81M	0.36M	7.73M	8.11M	7.92M
Total Current Liabilities (Quarter)	56.16M	94.59M	82.26M	82.36M	89.04M	81.82M	85.60M	63.82M	77.90M	79.22M	98.66M	98.48M	108.28M	64.83M	41.22M	31.32M	30.94M	22.43M	19.32M	19.34M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)	19.04M	16.12M	24.64M	50.44M	50.63M	50.86M	50.59M	51.23M	100.74M	101.14M	101.54M	102.01M	102.49M
Non-Current Deffered Revenue (Quarter)	78.43M	89.41M	87.00M	81.88M	90.01M	92.80M	92.43M	94.83M	94.93M	95.06M	95.36M	95.36M	95.36M
Liabilities from Discontinued Operations (Quarter)											66.92M
Operating Leases (Quarter)	13.83M	12.23M	17.96M	20.35M	19.52M	17.85M	107.94M	106.69M	106.71M	104.86M	91.65M	103.34M	100.94M	85.27M	82.97M	80.50M	77.96M	75.33M	72.58M	69.63M
Other Non-Current Liabilities (Quarter)	1.12M	8.20M	11.49M	3.91M	0.94M	0.96M		1.49M	1.97M	0.96M	1.63M	1.68M	1.73M		1.84M	1.90M	1.95M	2.01M	2.08M	2.14M
Total Non-Current Liabilities (Quarter)	167.46M	212.35M	211.86M	235.03M	249.19M	243.32M	338.00M	316.58M	381.81M	381.87M	401.83M	399.32M	407.08M	154.82M	124.19M	111.82M	108.90M	97.76M	91.90M	88.98M
Total Liabilities (Quarter)	168.58M	220.56M	223.35M	238.93M	250.14M	244.28M	338.00M	318.06M	383.77M	382.82M	403.46M	401.00M	408.81M	154.82M	126.03M	113.72M	110.85M	99.78M	93.97M	91.12M
Shareholder's Equity
Total Debt (Quarter)	19.04M	16.12M	24.64M	50.44M	50.63M	50.86M	50.59M	51.23M	100.74M	101.14M	101.54M	102.01M	102.49M
Common Equity (Quarter)	101.07M	175.74M	131.51M	80.96M	23.06M	67.58M	10.78M	-47.87M	22.61M	-15.12M	-44.86M	-59.74M	-87.07M	23.92M	13.78M	50.47M	32.95M	43.70M	44.22M	26.50M
Shareholder's Equity (Quarter)	101.07M	175.74M	131.51M	80.96M	23.06M	67.58M	10.78M	-47.87M	22.61M	-15.12M	-44.86M	-59.74M	-87.07M	23.92M	13.78M	50.47M	32.95M	43.70M	44.22M	26.50M
Liabilities and Shareholders Equity (Quarter)	269.65M	396.29M	354.86M	319.89M	273.20M	311.87M	348.78M	270.19M	406.39M	367.70M	358.60M	341.26M	321.73M	178.74M	139.81M	164.18M	143.80M	143.47M	138.19M	117.62M
Retained Earnings (Quarter)	-632.57M	-564.35M	-0.06M	-0.21M	-735.71M	-795.72M	-0.01M	0.00M	-889.13M	-936.99M	-978.24M	-1018.37M		-962.46M	-978.10M	-945.42M	-965.27M	-957.07M	-972.40M	-992.32M
Treasury Shares (Quarter)	0.46M	0.56M	0.73M	1.58M	1.58M	1.60M	1.55M	4.22M	3.94M	3.83M	3.38M	4.15M	3.81M	2.75M	0.08M	0.08M	0.05M	0.10M	0.02M	0.19M
Shares Outstanding (Quarter)	91.71M	91.84M	91.89M	92.21M	92.31M	124.41M	6.26M	126.59M	128.04M	128.63M	6.75M	7.57M	7.58M	8.51M	8.65M	8.73M	8.75M	8.76M	9.56M	9.59M

Research Tools

Seres Therapeutics Balance Sheet (2015-2026) | MCRB

Create an account

Sign In

Reset Password